|
AAMP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63850000234333E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78229999647783E-08 |
| Normal-vs-Stage2 |
2.858200E-03 |
| Normal-vs-Stage3 |
6.35090002809591E-09 |
| Normal-vs-Stage4 |
2.39849995420371E-09 |
| Stage1-vs-Stage2 |
3.547000E-01 |
| Stage1-vs-Stage3 |
1.897430E-01 |
| Stage1-vs-Stage4 |
8.083500E-02 |
| Stage2-vs-Stage3 |
8.538300E-02 |
| Stage2-vs-Stage4 |
4.265900E-02 |
| Stage3-vs-Stage4 |
5.078400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.88150006264732E-10 |
| Normal-vs-AfricanAmerican |
3.116500E-03 |
| Normal-vs-Asian |
9.17699999991584E-07 |
| Caucasian-vs-AfricanAmerican |
3.709200E-01 |
| Caucasian-vs-Asian |
8.052400E-01 |
| AfricanAmerican-vs-Asian |
4.803400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.0769999998822E-07 |
| Normal-vs-Female |
9.54060053182104E-10 |
| Male-vs-Female |
9.434600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.89349996687827E-09 |
| Normal-vs-Age(41-60Yrs) |
1.37020000012811E-07 |
| Normal-vs-Age(61-80Yrs) |
3.90920000037376E-07 |
| Normal-vs-Age(81-100Yrs) |
1.563670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.081200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.878400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.595000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.663000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.953000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.722800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.010160E-02 |
| Classical-VS-Follicular |
8.159800E-01 |
| Classical-VS-Other |
9.246400E-01 |
| Classical-VS-Normal |
3.56739970897024E-10 |
| Tall-VS-Follicular |
2.594100E-02 |
| Tall-VS-Other |
3.912200E-01 |
| Tall-VS-Normal |
2.81180001504566E-09 |
| Follicular-VS-Other |
9.751400E-01 |
| Follicular-VS-Normal |
2.341699999997E-05 |
| Other-VS-Normal |
1.677990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78240000003882E-06 |
| Normal-vs-N1 |
1.27330368471235E-11 |
| N0-vs-N1 |
2.365700E-04 |
|
|
